IQVIA delivered solid financial results in Q4 2021, reporting a 10.2% revenue growth to $62 million and a 20.9% increase in adjusted diluted earnings per share to $2.55. The company saw strong performance across all segments, with R&D and TAS showing mid-teens organic growth excluding COVID-related work. IQVIA's 20 by '25 strategy, aiming for $20 billion in revenue by 2025, is progressing well, with over 3,000 clients adopting its technology platforms. For 2022, revenue is projected between $14.700 billion and $15 billion, representing growth of 7.1% to 9.2% at constant currency. Adjusted EBITDA is anticipated to range from $3.330 billion to $3.405 billion, indicating a 10.2% to 12.7% growth, while adjusted diluted earnings per share are expected between $9.95 and $10.25, marking a 10.2% to 13.5% increase. Excluding COVID-related revenue, the FX headwind, and M&A contributions, IQVIA's total revenue growth implies organic growth at constant currency in the low to mid-teens.